Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DAVITA INC. Director's Dealing 2014

Feb 18, 2014

30643_dirs_2014-02-18_82454dda-7b59-49e0-be39-b69e3b1c0ed8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DAVITA HEALTHCARE PARTNERS INC. (DVA)
CIK: 0000927066
Period of Report: 2014-02-13

Reporting Person: Nissenson Allen (Chief Medical Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-02-13 Common Stock M 13168 $23.13 Acquired 16128 Direct
2014-02-13 Common Stock F 4591 $66.35 Disposed 11537 Direct
2014-02-13 Common Stock S 2547 $66.1601 Disposed 8990 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-02-13 Stock Appreciation Right $23.13 M 13168 Disposed 2014-03-02 Common Stock (13168) Direct

Footnotes

F1: Includes 452 shares issued on 12/31/2013 pursuant to the Employee Stock Purchase Plan.

F2: The range of prices for the sale of these shares was $66.16 - $66.1601. The filer undertakes to provide staff, the issuer or a security holder full information regarding the number of shares sold at each separate price.

F3: Stock Appreciation Rights, pursuant to the DaVita Inc. 2002 Equity Compensation Plan, (as amended and restated, the "DaVita HealthCare Partners Inc. 2011 Incentive Award Plan," effective June 6, 2011), which vested 25% on the first anniversary of the grant date, 8.33% on the 20th month following the grant date, and 8.33% every four months thereafter.